Hepta-, Octa-and nonapeptides having antiangiogenic activity

Details Hepta-, Octa-and nonapeptides having antiangiogenic activity Hepta-, Octa-and nonapeptides having antiangiogenic activity

2006-06-27

2006-06-27

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S016700, C530S328000, C530S329000

Reexamination Certificate

active

07067490

ABSTRACT:
Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

REFERENCES:
patent: 2003/0050246 (2003-03-01), Haviv et al.
patent: 2003/0228365 (2003-12-01), Haviv et al.
patent: 2003/0229022 (2003-12-01), Haviv et al.
patent: 99/61476 (1999-12-01), None
patent: 01/38347 (2001-05-01), None
patent: 01/38397 (2001-05-01), None
Reiher et al. Inhibition Of Tumor Growth By Systemic Treatment With Thrombospondin-1 Peptide Mimetics. International Journal Of Cancer. Vol. 98, pp. 682-689. (Apr. 10, 2002).

Affiliated with

Also associated with

Rating

Hepta-, Octa-and nonapeptides having antiangiogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepta-, Octa-and nonapeptides having antiangiogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepta-, Octa-and nonapeptides having antiangiogenic activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3649696